Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte–macrophage colony‐stimulating factor for murine ovarian cancerFumi Goshima, Yukihiro Nishiyama|International Journal of Cancer|2013Cited by 34